This pharma name targeting aging has soared this year. BTIG thinks it can double from here
- Posted on May 13, 2026
- By CNBC
- 1 Views
- 1 min read
This pharma name targeting aging has soared this year. BTIG thinks it can double from here
The investment firm initiated coverage of the biopharmaceutical name with a buy rating.
